Ventria Bioscience: Difference between revisions

Latest revision as of 11:05, 15 February 2025

Ventria Bioscience[edit]

Ventria Bioscience logo

Ventria Bioscience is a biotechnology company that specializes in the development and commercialization of recombinant proteins derived from plant-based expression systems. The company is known for its innovative use of genetically modified organisms (GMOs) to produce proteins that are used in pharmaceuticals, nutraceuticals, and other health-related products.

History[edit]

Ventria Bioscience was founded with the goal of harnessing the power of plant biotechnology to produce high-value proteins. The company has developed a proprietary technology platform that utilizes rice as a host plant for the production of recombinant proteins. This approach offers several advantages, including scalability, cost-effectiveness, and safety.

Technology[edit]

Ventria's core technology involves the use of transgenic rice plants to express therapeutic proteins. The process begins with the insertion of specific genes into the rice genome, enabling the plant to produce the desired protein. Once the rice plants are harvested, the proteins are extracted and purified for use in various applications.

Advantages of Plant-Based Expression[edit]

File:Ventria-logo.PNG

Ventria's plant-based expression system

The use of plant-based expression systems offers several benefits over traditional methods of protein production, such as those using bacteria or mammalian cell cultures. These advantages include:

Cost Efficiency: Plant-based systems can be more cost-effective due to lower production and maintenance costs.
Scalability: Plants can be grown on a large scale, allowing for the mass production of proteins.
Safety: Plant systems reduce the risk of contamination with human pathogens, making them safer for producing therapeutic proteins.

Products[edit]

Ventria Bioscience has developed a range of products that utilize its plant-based expression technology. These products include:

Recombinant Human Lactoferrin: Used in infant formula and dietary supplements for its immune-boosting properties.
Recombinant Human Lysozyme: Applied in oral rehydration solutions to help manage diarrhea and improve gut health.

Applications[edit]

The proteins produced by Ventria Bioscience have a wide range of applications in the biotechnology and healthcare industries. They are used in:

Pharmaceuticals: As active ingredients in drugs and therapeutic treatments.
Nutraceuticals: In health supplements and functional foods.
Research: As reagents in scientific studies and experiments.

Controversies[edit]

The use of genetically modified organisms in agriculture and biotechnology has been a topic of debate. Ventria Bioscience has faced challenges related to the public perception of GMOs and regulatory hurdles in the approval of its products.

Related pages[edit]

@@ Line 1: / Line 1: @@
-'''Ventria Bioscience''' is a [[biotechnology]] company that specializes in the development and commercialization of plant-made pharmaceuticals. The company was founded in 1993 and is headquartered in [[Sacramento]], [[California]], United States.
+== Ventria Bioscience ==
+[[File:Ventria-logo.PNG|thumb|right|Ventria Bioscience logo]]
+'''Ventria Bioscience''' is a biotechnology company that specializes in the development and commercialization of recombinant proteins derived from [[plant-based expression systems]]. The company is known for its innovative use of [[genetically modified organisms]] (GMOs) to produce proteins that are used in [[pharmaceuticals]], [[nutraceuticals]], and other health-related products.
 == History ==
-Ventria Bioscience was established in 1993 with the aim of developing and commercializing plant-made pharmaceuticals. The company's initial focus was on the production of [[recombinant proteins]] in plants, a process known as [[molecular farming]] or [[pharming (genetics)|pharming]].
+Ventria Bioscience was founded with the goal of harnessing the power of plant biotechnology to produce high-value proteins. The company has developed a proprietary technology platform that utilizes [[rice]] as a host plant for the production of recombinant proteins. This approach offers several advantages, including scalability, cost-effectiveness, and safety.
 == Technology ==
-Ventria Bioscience utilizes a proprietary technology platform known as ExpressTec. This technology enables the production of recombinant proteins in the seeds of [[rice]] plants. The proteins can then be extracted and purified for use in pharmaceutical applications. ExpressTec has been used to produce a variety of proteins, including [[lactoferrin]], [[lysozyme]], and [[human serum albumin]].
+Ventria's core technology involves the use of [[transgenic]] rice plants to express therapeutic proteins. The process begins with the insertion of specific [[genes]] into the rice genome, enabling the plant to produce the desired protein. Once the rice plants are harvested, the proteins are extracted and purified for use in various applications.
+=== Advantages of Plant-Based Expression ===
+[[File:Ventria-logo.PNG|thumb|left|Ventria's plant-based expression system]]
+The use of plant-based expression systems offers several benefits over traditional methods of protein production, such as those using [[bacteria]] or [[mammalian cell cultures]]. These advantages include:
+* '''Cost Efficiency''': Plant-based systems can be more cost-effective due to lower production and maintenance costs.
+* '''Scalability''': Plants can be grown on a large scale, allowing for the mass production of proteins.
+* '''Safety''': Plant systems reduce the risk of contamination with human pathogens, making them safer for producing therapeutic proteins.
 == Products ==
-Ventria Bioscience has developed several products using its ExpressTec technology. These include a rehydration solution called InVitria, which contains recombinant human lactoferrin and lysozyme. The company has also developed a line of skincare products under the brand name Vantria, which contain recombinant human lactoferrin.
+Ventria Bioscience has developed a range of products that utilize its plant-based expression technology. These products include:
+* '''Recombinant Human Lactoferrin''': Used in [[infant formula]] and [[dietary supplements]] for its immune-boosting properties.
+* '''Recombinant Human Lysozyme''': Applied in [[oral rehydration solutions]] to help manage [[diarrhea]] and improve gut health.
+== Applications ==
+The proteins produced by Ventria Bioscience have a wide range of applications in the [[biotechnology]] and [[healthcare]] industries. They are used in:
+* '''Pharmaceuticals''': As active ingredients in drugs and therapeutic treatments.
+* '''Nutraceuticals''': In health supplements and functional foods.
+* '''Research''': As reagents in scientific studies and experiments.
 == Controversies ==
-Ventria Bioscience has faced controversy over its use of genetically modified rice plants to produce pharmaceuticals. Critics argue that this could lead to the contamination of the food supply, while the company maintains that it has implemented strict controls to prevent such contamination.
-== See also ==
+The use of genetically modified organisms in agriculture and biotechnology has been a topic of debate. Ventria Bioscience has faced challenges related to the public perception of GMOs and regulatory hurdles in the approval of its products.
-* [[Biopharming]]
-* [[Genetically modified crops]]
+== Related pages ==
+* [[Biotechnology]]
+* [[Genetically modified organism]]
 * [[Recombinant DNA]]
+* [[Pharmaceutical industry]]
-== References ==
+[[Category:Biotechnology companies]]
-<references />
+[[Category:Genetic engineering]]
-[[Category:Biotechnology companies of the United States]]
-[[Category:Companies based in Sacramento, California]]
-[[Category:Pharmaceutical companies of the United States]]
-{{Biotech-stub}}